Skip to main content
. 2011 Jul 27;6(7):e21554. doi: 10.1371/journal.pone.0021554

Table 3. Results of whole blood assay tests.

TXBInline graphic [%] PGEInline graphic [%]
ID 1 Inline graphic 10 Inline graphic 100 Inline graphic 1 Inline graphic 10 Inline graphic 100 Inline graphic
Inline graphic 122± 15.0 94± 3.4 81± 1.2 105± 4.9 112± 8.4 97± 19.9
Inline graphic 93± 22.7 88± 6.9 25± 5.3 80± 9.0 70± 3.1 25± 0.5
Inline graphic 107± 0.0 107± 2.8 91± 2.3 93± 15.8 91± 8.9 88± 34.5
Inline graphic 102± 3.5 91± 4.4 85± 1.8 110± 12.3 111± 16.5 105± 22.0
Inline graphic 100± 0.9 98± 1.3 71± 1.3 105± 7.9 118± 6.9 106± 33.8
Inline graphic 97± 3.8 82± 6.6 28± 2.4 109± 3.6 91± 7.4 74± 9.1
Inline graphic 102± 6.3 89± 12.1 77± 5.8 99± 13.7 86± 11.9 93± 21.2
Inline graphic 93± 2.8 77± 13.3 39± 1.2 97± 2.5 155± 6.7 322± 27.5
Inline graphic 86± 6.9 71± 2.3 67± 12.1 73± 6.1 84± 9.8 89± 3.1
Inline graphic 97± 3.8 82± 6.6 28± 2.4 91± 4.2 94± 2.9 90± 6.3
Inline graphic 92± 1.8 87± 2.7 60± 1.9 105± 2.1 98± 9.2 69± 6.7
Inline graphic 100± 1.3 85± 4.4 80± 0.9 102± 10.6 120± 9.4 113± 14.5

TXBInline graphic is indicative of COX-1 activity, PGEInline graphic of COX-2 activity relative to DMSO control. Primed (Inline graphic) compounds are shown in Fig. 8, starred (Inline graphic) compounds are shown in Fig. 9. Discussed compounds are shown in bold face.